Emerging infections: how and why they arise
Updated 5 January 2023
How infections emerge
Between 60% and 80% of emerging infections are derived from animal sources.
Infectious disease emergence involves 2 main steps:
- An agent is introduced into a new host population.
- The agent is established and transmitted within the new host population.
Infections have been emerging for thousands of years as interactions between humans, animals and their environments have increased and changed.
Reasons for emergence
Disease emergence results from interactions between microbes and humans. These can be complex and multi-factorial. For example, population movement may result in the spread of a previously localised infection to a city where there is poor public health infrastructure, resulting in its establishment in the wider population. The city may then act as a source for further spread.
Factors involved in emergence are outlined below.
Microbial adaptation and change
Microbes continually adapt to the environment in which they live. The changes that result may enable them to evade the human immune system or provide them with a new ability to invade human or animal cells. They can also develop resistance to drug treatments, such as antibiotics, or undergo changes that result in vaccines being less effective.
Ecological changes
Ecological changes, including those due to agricultural or economic development, are among the most frequently identified factors in disease emergence.
Changes in the way land is used can result in humans coming into contact with animals and insect vectors, including:
- urbanisation
- agricultural practices
- deforestation
- reforestation
- dam building
- irrigation
These changes can increase the risk of human exposure to a potentially infectious disease.
Climate change can have a direct impact on how diseases are spread; either through effects on microbes and vectors (for example, a warmer climate may provide more favourable conditions in new geographical areas for insects, such as ticks and mosquitoes, which can carry and transmit disease) or because we may modify our behaviour in response to climate change.
Transmission of infectious diseases may also increase as a result of short-term weather conditions (for example, drought or flooding affecting cholera outbreaks) or appear at particular times of the year (for example, influenza in the winter).
Human demographics and behaviour
Activities such as sexual contact, drug use or outdoor recreational activities can result in increased exposure to an infectious microbe. Infections can then rapidly spread, especially in more heavily populated areas or where there are population movements or upheavals.
‘Bush meat’ harvested from previously remote forested areas remains a risk for animal-derived emerging infections. Other factors driving emergence include poverty, social inequality and lack of political will.
Technology and healthcare
Some diseases emerge as a direct consequence of technological change. New medical treatments and procedures like blood transfusion and organ transplantation, including xenotransplantation (the use of animal tissues or organs in humans), have created new ways for microbes to spread and infect people.
Travel, trade and industry
The speed and ease with which humans, animals and other goods can be transported around the world has made it much easier to spread both microbes and the vectors or vehicles that can transmit them.
Changes in food processing and packaging, and animal farming (including the widespread use of antibiotics in farm animals) also provide the potential for new diseases to emerge and spread.
Breakdown in public health measures
The spread of existing infections and the emergence of new ones in many areas of the world can be caused by poor sanitary conditions, hygiene and a lack of clean drinking water. Breakdown of public health measures, such as spraying mosquitoes (vector control) or vaccination programmes, can result in the re-emergence of previously controlled diseases.
Susceptibility to infection
The human body has many defences against infection. These defences can become weakened through disease, increasing age or other influences (for example malnutrition) making individuals more vulnerable to infection. Low vaccine uptake may result in populations becoming more susceptible to infection.
Emerging infections in humans between 2003 and 2022
The following timeline and map show newly identified emerging infections and notable outbreaks of diseases in humans in new areas between 2003 and 2022. The information is also presented in the table below.
Timeline of newly identified emerging infections and notable outbreaks of diseases in humans in new areas between 2003 and 2022
Global map of newly identified emerging infections and notable outbreaks of diseases in humans in new areas between 2003 and 2022
Table of newly identified emerging infections and notable outbreaks of diseases in humans in new areas between 2003 and 2022
Year | Disease | Location | Category |
---|---|---|---|
2022 | |||
2022 | Langya henipavirus | China | Newly identified emerging infection |
2022 | Avian influenza A(H3N8) | China | Newly identified emerging infection |
2022 | Avian influenza A(H5N1) | Spain | Disease identified in new area |
2022 | Avian influenza A(H5N1) | UK | Disease identified in new area |
2022 | Avian influenza A(H5N1) | USA | Disease identified in new area |
2022 | Dengue | São Tomé and Príncipe | Disease identified in new area |
2022 | Marburg virus | Ghana | Disease identified in new area |
2022 | Mpox (monkeypox) virus | Global | Disease identified in new area |
2021 | |||
2021 | Alto Paraguay virus | Argentina | Newly identified emerging infection |
2021 | Avian influenza A(H5N8) | Russia | Newly identified emerging infection |
2021 | Avian influenza A(H10N3) | China | Newly identified emerging infection |
2021 | Yezo virus | Japan | Newly identified emerging infection |
2021 | Avian influenza A(H5N1) | India | Disease identified in new area |
2021 | Avian influenza A(H5N6) | Laos | Disease identified in new area |
2021 | Marburg virus | Guinea | Disease identified in new area |
2020 | |||
2020 | Guinea worm sp. nov. | Vietnam | Newly identified emerging infection |
2020 | Chikungunya | Chad | Disease identified in new area |
2020 | Oropouche virus | French Guiana | Disease identified in new area |
2020 | Severe fever with thrombocytopenia syndrome | Thailand | Disease identified in new area |
2019 | |||
2019 | SARS-CoV-2 | Global | Newly identified emerging infection |
2019 | Avian influenza A(H5N1) | Nepal | Disease identified in new area |
2019 | Dengue | Afghanistan | Disease identified in new area |
2019 | Rift Valley fever | Central African Republic | Disease identified in new area |
2019 | Tick-borne encephalitis | UK | Disease identified in new area |
2019 | West Nile virus | Germany | Disease identified in new area |
2018 | |||
2018 | Avian influenza A(H7N4) | China | Newly identified emerging infection |
2018 | Guinea worm | Angola | Disease identified in new area |
2017 | |||
2017 | Rat hepatitis E | China | Newly identified emerging infection |
2017 | Lyme disease | Nepal | Disease identified in new area |
2016 | |||
2016 | Ntwetwe virus | Uganda | Newly identified emerging infection |
2016 | Crimean-Congo haemorrhagic fever | Spain | Disease identified in new area |
2016 | Lassa fever | Togo | Disease identified in new area |
2015 | |||
2015 | Zika virus | Brazil | Disease identified in new area |
2014 | |||
2014 | Chikungunya | Brazil | Disease identified in new area |
2014 | Bourbon virus | USA | Newly identified emerging infection |
2014 | Avian influenza A(H5N6) | China | Newly identified emerging infection |
2014 | Lassa fever | Benin | Disease identified in new area |
2014 | Ebola virus | Guinea, Liberia, Sierra Leone | Disease identified in new area |
2013 | |||
2013 | Avian influenza A(H7N9) | China | Newly identified emerging infection |
2013 | Avian influenza A(H10N8) | China | Newly identified emerging infection |
2013 | Colpodella spp. Heilongjiang (HLJ) | China | Newly identified emerging infection |
2013 | Sosuga virus | Uganda, South Sudan | Newly identified emerging infection |
2013 | Variegated Squirrel Bornavirus 1 (VSBV-1) | Germany | Newly identified emerging infection |
2013 | Chikungunya | Caribbean | Disease identified in new area |
2012 | |||
2012 | Middle East respiratory syndrome coronavirus (MERS-CoV) | Middle East | Newly identified emerging infection |
2012 | Mojiang paramyxovirus | China | Newly identified emerging infection |
2012 | Severe fever with thrombocytopenia syndrome | Japan, South Korea | Disease identified in new area |
2011 | |||
2011 | Influenza A(H3N2)v | USA | Newly identified emerging infection |
2011 | Plasmodium cynomolgi | Malaysia | Newly identified emerging infection |
2011 | Lassa fever | Ghana | Disease identified in new area |
2010 | |||
2010 | Cholera | Haiti | Disease identified in new area |
2009 | |||
2009 | Bas-Congo virus | DRC | Newly identified emerging infection |
2009 | Candida auris sp. nov. | Japan | Newly identified emerging infection |
2009 | Heartland virus | USA | Newly identified emerging infection |
2009 | Influenza A(H1N1) | Global | Newly identified emerging infection |
2009 | Severe fever with thrombocytopenia syndrome | China | Newly identified emerging infection |
2009 | Lassa fever | Mali | Disease identified in new area |
2008 | |||
2008 | Lujo virus | South Africa and Zambia | Newly identified emerging infection |
2008 | Crimean-Congo haemorrhagic fever | Greece | Disease identified in new area |
2007 | |||
2007 | Chikungunya | Italy | Disease identified in new area |
2005 | |||
2005 | Human T-lymphotropic virus (HTLV) 3 | Cameroon | Newly identified emerging infection |
2005 | HTLV 4 | Cameroon | Newly identified emerging infection |
2003 | |||
2003 | Chapare virus | Bolivia | Newly identified emerging infection |